Huntsman Co. (NYSE:HUN – Get Rating) – Investment analysts at KeyCorp lowered their Q2 2023 earnings per share estimates for shares of Huntsman in a research report issued on Monday, April 10th. KeyCorp analyst A. Yefremov now expects that the basic materials company will earn $0.34 per share for the quarter, down from their previous estimate of $0.35. The consensus estimate for Huntsman’s current full-year earnings is $1.85 per share. KeyCorp also issued estimates for Huntsman’s Q3 2023 earnings at $0.49 EPS, Q4 2023 earnings at $0.56 EPS and FY2023 earnings at $1.51 EPS.
Several other analysts have also recently issued reports on HUN. Royal Bank of Canada reduced their price objective on Huntsman from $33.00 to $30.00 and set a “sector perform” rating on the stock in a research note on Thursday, February 23rd. UBS Group increased their price target on Huntsman from $27.00 to $32.00 and gave the company a “neutral” rating in a research report on Wednesday, January 11th. Mizuho initiated coverage on Huntsman in a research report on Wednesday. They set a “neutral” rating and a $27.00 price objective for the company. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Huntsman from $33.00 to $31.00 in a report on Wednesday, February 22nd. Finally, Wells Fargo & Company lifted their price target on shares of Huntsman from $28.00 to $31.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 22nd. Three analysts have rated the stock with a sell rating, eleven have given a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $30.58.
Huntsman Price Performance
Huntsman (NYSE:HUN – Get Rating) last issued its quarterly earnings results on Tuesday, February 21st. The basic materials company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.11 by ($0.07). The business had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.58 billion. Huntsman had a return on equity of 16.03% and a net margin of 5.47%. The firm’s revenue for the quarter was down 21.9% compared to the same quarter last year. During the same period in the prior year, the company posted $0.95 EPS.
Huntsman Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, March 31st. Shareholders of record on Wednesday, March 15th were paid a $0.2375 dividend. This represents a $0.95 annualized dividend and a yield of 3.54%. The ex-dividend date was Tuesday, March 14th. This is an increase from Huntsman’s previous quarterly dividend of $0.21. Huntsman’s dividend payout ratio is currently 43.98%.
Institutional Trading of Huntsman
Large investors have recently made changes to their positions in the company. Byrne Asset Management LLC purchased a new stake in Huntsman in the third quarter valued at approximately $26,000. Exchange Traded Concepts LLC acquired a new position in shares of Huntsman in the 4th quarter valued at $27,000. Brown Brothers Harriman & Co. purchased a new stake in Huntsman in the 1st quarter valued at $30,000. CoreCap Advisors LLC purchased a new position in Huntsman during the 4th quarter worth $32,000. Finally, Wipfli Financial Advisors LLC acquired a new position in Huntsman in the third quarter valued at $34,000. 87.57% of the stock is owned by institutional investors and hedge funds.
About Huntsman
Huntsman Corp. engages in the manufacturing of differentiated organic chemical products. It operates through the following segments: Polyurethanes, Performance Products, and Advanced Materials. The Polyurethanes segment manufactures and markets polyurethane chemicals, including MDI products, PO, polyols, PG, TPU, aniline, and MTBE.
Featured Stories
- Get a free copy of the StockNews.com research report on Huntsman (HUN)
- Should Cheesecake Factory Stock Be On Your Menu?
- Buffett Reduces Taiwan Semiconductor Stake After This Happened
- Don’t Get Bullish On The S&P 500 Because Of The CPI Report
- Shockwave Medical Gets 10% Jolt, Leads Medical Gear Makers Higher
- Proterra Inc., A Penny Stock To Put On The Watchlist
Receive News & Ratings for Huntsman Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huntsman and related companies with MarketBeat.com's FREE daily email newsletter.